OBJECTIVE: To derive and validate a risk score for an adverse clinical outcome in adults with meningitis and a negative cerebrospinal fluid (CSF) Gram stain. PATIENTS AND METHODS: We conducted a retrospective study of 567 adults from Houston, Texas, with meningitis evaluated between January 1, 2005, and January 1, 2010. The patients were divided into derivation (N=292) and validation (N=275) cohorts. An adverse clinical outcome was defined as a Glasgow Outcome Scale score of 4 or less. RESULTS: Of the 567 patients, 62 (11%) had an adverse clinical outcome. A predictive model was created using 3 baseline variables that were independently associated with an adverse clinical outcome (P<.05): age greater than 60 years, abnormal findings on neurologic examination (altered mental status, focal neurologic deficits, or seizures), and CSF glucose level of less than 2.4975 mmol/L (to convert CSF glucose to mmol/L, multiply by 0.05551). The model classified patients into 2 categories of risk for an adverse clinical outcome--derivation sample: low risk, 0.6% and high risk, 32.8%; P<.001; and validation sample: low risk, 0.5% and high risk, 21.1%; P<.001. CONCLUSION: Adults with meningitis and a negative CSF Gram stain can be accurately stratified for the risk of an adverse clinical outcome using clinical variables available at presentation.
OBJECTIVE: To derive and validate a risk score for an adverse clinical outcome in adults with meningitis and a negative cerebrospinal fluid (CSF) Gram stain. PATIENTS AND METHODS: We conducted a retrospective study of 567 adults from Houston, Texas, with meningitis evaluated between January 1, 2005, and January 1, 2010. The patients were divided into derivation (N=292) and validation (N=275) cohorts. An adverse clinical outcome was defined as a Glasgow Outcome Scale score of 4 or less. RESULTS: Of the 567 patients, 62 (11%) had an adverse clinical outcome. A predictive model was created using 3 baseline variables that were independently associated with an adverse clinical outcome (P<.05): age greater than 60 years, abnormal findings on neurologic examination (altered mental status, focal neurologic deficits, or seizures), and CSF glucose level of less than 2.4975 mmol/L (to convert CSF glucose to mmol/L, multiply by 0.05551). The model classified patients into 2 categories of risk for an adverse clinical outcome--derivation sample: low risk, 0.6% and high risk, 32.8%; P<.001; and validation sample: low risk, 0.5% and high risk, 21.1%; P<.001. CONCLUSION: Adults with meningitis and a negative CSF Gram stain can be accurately stratified for the risk of an adverse clinical outcome using clinical variables available at presentation.
Authors: Allan R Tunkel; Barry J Hartman; Sheldon L Kaplan; Bruce A Kaufman; Karen L Roos; W Michael Scheld; Richard J Whitley Journal: Clin Infect Dis Date: 2004-10-06 Impact factor: 9.079
Authors: François G Brivet; Sophie Ducuing; Frédéric Jacobs; Isabelle Chary; Roger Pompier; Dominique Prat; Bogdan D Grigoriu; Patrice Nordmann Journal: Intensive Care Med Date: 2005-10-22 Impact factor: 17.440
Authors: Patrick Ray; Ghislaine Badarou-Acossi; Alain Viallon; David Boutoille; Martine Arthaud; David Trystram; Bruno Riou Journal: Am J Emerg Med Date: 2007-02 Impact factor: 2.469
Authors: L Nesher; C M Hadi; L Salazar; S H Wootton; K W Garey; T Lasco; A M Luce; R Hasbun Journal: Epidemiol Infect Date: 2015-05-20 Impact factor: 4.434
Authors: Maxime O Baud; Jeffrey R Vitt; Nathaniel M Robbins; Rafael Wabl; Michael R Wilson; Felicia C Chow; Jeffrey M Gelfand; S Andrew Josephson; Steve Miller Journal: Neurol Neuroimmunol Neuroinflamm Date: 2017-12-22